These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 26344593)

  • 1. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
    Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
    Papadopoulou MV; Bloomer WD; Lepesheva GI; Rosenzweig HS; Kaiser M; Aguilera-Venegas B; Wilkinson SR; Chatelain E; Ioset JR
    J Med Chem; 2015 Feb; 58(3):1307-19. PubMed ID: 25580906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
    J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
    Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M
    Eur J Med Chem; 2016 Nov; 123():895-904. PubMed ID: 27543881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M
    Eur J Med Chem; 2017 Sep; 138():1106-1113. PubMed ID: 28763645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.
    Papadopoulou MV; Trunz BB; Bloomer WD; McKenzie C; Wilkinson SR; Prasittichai C; Brun R; Kaiser M; Torreele E
    J Med Chem; 2011 Dec; 54(23):8214-23. PubMed ID: 22023653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-
    Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
    Hall BS; Meredith EL; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5821-30. PubMed ID: 22948871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M
    Eur J Med Chem; 2016 Jul; 117():179-86. PubMed ID: 27092415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi.
    Pirttimaa M; Nasereddin A; Kopelyanskiy D; Kaiser M; Yli-Kauhaluoma J; Oksman-Caldentey KM; Brun R; Jaffe CL; Moreira VM; Alakurtti S
    J Nat Prod; 2016 Feb; 79(2):362-8. PubMed ID: 26849852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
    Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
    Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Ashworth R; Wilkinson SR; Kaiser M; Andriani G; Rodriguez A
    Future Med Chem; 2013 Oct; 5(15):1763-76. PubMed ID: 24144412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
    Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
    J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.
    Moraes CB; Giardini MA; Kim H; Franco CH; Araujo-Junior AM; Schenkman S; Chatelain E; Freitas-Junior LH
    Sci Rep; 2014 Apr; 4():4703. PubMed ID: 24736467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.
    Tasdemir D; Kaiser M; Brun R; Yardley V; Schmidt TJ; Tosun F; Rüedi P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1352-64. PubMed ID: 16569852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.